Your browser doesn't support javascript.
Candida auris and COVID-19: A health threatening combination.
Khojasteh, Shaghayegh; Jafarzdeh, Jalal; Hosseini, Seyed Abdollah; Haghani, Iman; Turki, Habibollah; Aghaei Gharehbolagh, Sanaz; Abastabar, Mahdi; Mahmoudi, Shahram.
  • Khojasteh S; Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
  • Jafarzdeh J; Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
  • Hosseini SA; Department of Medical Mycology and Parasitology, School of Medicine, Babol University of Medical Sciences, Babol, Iran.
  • Haghani I; Toxoplasmosis Research Center, Communicable Diseases, Institute, Mazandaran University of Medical Sciences, Mazandaran, Sari, Iran.
  • Turki H; Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
  • Aghaei Gharehbolagh S; Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
  • Abastabar M; Molecular Medecine Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
  • Mahmoudi S; Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Curr Med Mycol ; 8(3): 44-50, 2022 Sep.
Article in English | MEDLINE | ID: covidwho-2266271
ABSTRACT
Since its first emergence in December 2019, due to its fast distribution throughout the world, SARS-COV-2 become a global concern. With the extremely increased number of hospitalized patients, this situation provided a potential basis for the transmission of nosocomial infections. Candida auris is a multidrug-resistant pathogen with improved transmission dynamics and resistance traits. During the worldwide spread of COVID-19, cases or outbreaks of C. auris colonization or infection have been reported. Resistance to antifungal drugs has been observed in the causative agents of the majority of such cases. The focus in this review is on COVID-19-associated C. auris infections (case studies/outbreaks) and the pandemic's potential effect on antifungal drug resistance.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Curr Med Mycol Year: 2022 Document Type: Article Affiliation country: CMM.8.3.11211

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Curr Med Mycol Year: 2022 Document Type: Article Affiliation country: CMM.8.3.11211